Streetbeat News

Analyst Ratings

ABT

Abbott Laboratories reported strong Q3 results with sales of $10.64 billion, beating expectations. The company projects continued growth, with a robust product pipeline expected to drive earnings growth into 2025. William Blair maintains an Outperform rating on Abbott, citing attractive valuation and potential EPS upside.

Portfolio Pulse from Vandana Singh

October 17, 2024 | 6:42 pm

MSFT

Bank of America Securities analyst Bradley Sills reiterated a Buy rating on Microsoft Corp (NASDAQ:MSFT) with a price target of $510, citing growth in Azure, Office 365, and gaming. Despite a revenue mix shift towards lower-margin segments, stable margin expansion is expected. The stock is trading at 32 times the calendar year 2026 free cash flow, with potential for multiple expansions.

Portfolio Pulse from Anusuya Lahiri

October 17, 2024 | 6:35 pm

ALMS

BMY

TAK

HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS) with a Buy rating and a $30 price target, citing its lead drug candidate ESK-001's superior profile over Bristol Myers' Sotyktu. ESK-001 is in Phase 3 trials for psoriasis and Phase 2 for lupus, with potential peak sales of $1.9 billion and $2.0 billion, respectively.

Portfolio Pulse from Vandana Singh

October 17, 2024 | 6:32 pm

SNA

Barrington Research has maintained an 'Outperform' rating on Snap-on and raised its price target from $325 to $350.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:26 pm

FWRG

Stephens & Co. analyst Jim Salera initiated coverage on First Watch Restaurant Group, Inc. (NASDAQ:FWRG) with an Overweight rating and a $20 price target. Despite tough macro conditions, First Watch is expected to achieve significant growth, aiming for over 2,200 domestic locations. The analyst forecasts annual revenue growth in the low double digits, driven by unit growth and same-store sales. However, challenges such as a tough consumer environment and Hurricane Milton could impact revenue.

Portfolio Pulse from Nabaparna Bhattacharya

October 17, 2024 | 6:22 pm

TYL

DA Davidson analyst Peter Heckmann maintains a Neutral rating on Tyler Technologies (NYSE:TYL) and raises the price target from $525 to $550.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:21 pm

S

DA Davidson analyst Rudy Kessinger maintains a Neutral rating on SentinelOne (NYSE:S) and raises the price target from $23 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:20 pm

OKTA

DA Davidson analyst Rudy Kessinger maintains a Neutral rating on Okta and lowers the price target from $85 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:19 pm

USB

DA Davidson analyst Peter Winter maintains a Neutral rating on U.S. Bancorp (NYSE:USB) but raises the price target from $49 to $54.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:17 pm

EQBK

DA Davidson analyst Jeff Rulis maintains a Neutral rating on Equity Bancshares (NYSE:EQBK) and raises the price target from $42 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 6:15 pm